{"DataElement":{"publicId":"7190060","version":"1","preferredName":"Subcategory for Concomitant Medication","preferredDefinition":"A sub-division of the CMCAT values based on sponsor defined characteristics.","longName":"CM_CMSCAT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6400388","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Subcategory","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._A subdivision of concomitant medication data.","longName":"4550855v1.0:6400386v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4550855","version":"1","preferredName":"Concomitant Medication Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","longName":"C49568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Domain","conceptCode":"C49568","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06047D53-A3ED-FF3E-E050-BB89AD430B5B","latestVersionIndicator":"Yes","beginDate":"2014-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-22","modifiedBy":"ONEDATA","dateModified":"2014-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6400386","version":"1","preferredName":"Concomitant Medication Subcategory","preferredDefinition":"A subdivision of concomitant medication data.","longName":"C83232","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Subcategory","conceptCode":"C83232","definition":"A subdivision of concomitant medication data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7369B93D-7385-522D-E053-F662850AF758","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7369B93D-7396-522D-E053-F662850AF758","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"SOKKERL","dateModified":"2020-09-03","changeDescription":"created for CDASH 8/14/18LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7185234","version":"1","preferredName":"Concomitant Medication Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of concomitant medication data._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._Something distinguishable as an identifiable class based on common qualities.","longName":"CMSCAT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F65D847-5C0D-1CC3-E053-F662850AC96F","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7185233","version":"1","preferredName":"Concomitant Medication Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of concomitant medication data.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:Something distinguishable as an identifiable class based on common qualities.","longName":"C83232:C70793:C165683:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Subcategory","conceptCode":"C83232","definition":"A subdivision of concomitant medication data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F65D847-5BE6-1CC3-E053-F662850AC96F","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"ONEDATA","dateModified":"2020-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F65D847-5BF7-1CC3-E053-F662850AC96F","latestVersionIndicator":"Yes","beginDate":"2020-02-25","endDate":"2022-07-12","createdBy":"TAYLORT","dateCreated":"2020-02-25","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/25/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released during quarterly metrics and per request from G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the subcategory for t","type":"Preferred Question Text","description":"What is the subcategory for the (concomitant) [medication/treatment/therapy]?","url":null,"context":"NRDS"},{"name":"CDASH Prompt","type":"Alternate Question Text","description":"(Concomitant) [Medication/Treatment/Therapy subcategory]; NULL","url":null,"context":"NRDS"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Record (concomitant) [medication/treatment/therapy] subcategory, if not pre-printed on the CRF.","url":null,"context":"NRDS"},{"name":"CMSCAT","type":"CDASH to SDTM Mapping","description":"Maps directly to the SDTMIG variable.","url":null,"context":"NRDS"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Sponsor-defined Controlled Terminology. This would most commonly be pre-printed on the CRF or screen and pre-populated in the data management system. This is not typically a question to which the site would provide an answer.","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A01DE450-9EAF-15D3-E053-F662850A9808","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-05","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"3-5-20 tmt created for sponsor-defined codelists.","administrativeNotes":"07.14.22_Released as part of the quarterly metrics and per request of G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}